Cover Image
市場調查報告書

美國的腫瘤切除設備市場分析

US Market Report for Tumor Ablation Devices - MedCore

出版商 iData Research Inc. 商品編碼 360606
出版日期 內容資訊 英文 100 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的腫瘤切除設備市場分析 US Market Report for Tumor Ablation Devices - MedCore
出版日期: 2016年02月01日 內容資訊: 英文 100 Pages
簡介

本報告提供美國的腫瘤切除設備的市場相關分析,各類別的市場規模的變化及預測 (過去4年、今後7年份) ,及各產品的詳細趨勢調查、估計,整體市場結構,主要的推動及阻礙市場要素,近幾年的企業間競爭情勢的資訊彙整,為您概述為以下內容。

摘要整理

分析方法

  • 分析範圍
  • IDATA的9階段的分析方法

癌症的發病率

  • 簡介
  • 癌症的各種類的趨勢
    • 性器官癌症
    • 消化器官癌症
    • 呼吸系統癌症
    • 乳癌
    • 尿道癌症
    • 皮膚癌症
    • 淋巴瘤
    • 內分泌系癌症
    • 白血病
    • 口腔癌症/咽癌症
    • 骨髓瘤
    • 腦瘤/神經系統腫瘤
    • 軟組織 (心臟之外)的癌症
    • 骨腫瘤、關節腫瘤
    • 眼腫瘤、眼窩肉瘤

腫瘤切除設備市場

  • 簡介
    • 手法 (模式)
      • 冷凍消融
      • 高頻 (RF) 切除
      • 微波切除
      • 雷射消熔
      • 高強度焦點超音波 (HIFU) 切除
      • 不可逆電力穿孔法 (IRE) 切除
  • 市場概要
  • 市場分析與預測
    • 冷凍消融設備市場
      • 設備市場
      • 設備出租市場
      • 探針市場
    • 微波切除設備市場
      • 設備市場
      • 設備出租市場
      • 探針市場
    • RF切除設備市場
      • RF發生設備市場
      • 消耗品市場
  • 推動及阻礙市場要素
    • 推動市場要素
    • 阻礙市場要素
  • 競爭分析

簡稱一覽

圖表一覽

目錄
Product Code: iDATA_USTABL16_RPT

Ablation therapy is a minimally invasive procedure that is used to destroy unwanted tissue in a variety of cases. Ablation may be performed via probes, catheters or with energy beams. Most ablation technologies have a base unit and accompanying probes. Imaging machines help guide the surgeon to the problem area.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY FOR COMPLETE REPORT SUITE

  • 1.1. MARKET OVERVIEW
  • 1.2. COMPETITIVE LANDSCAPE
  • 1.3. MARKET TRENDS
  • 1.4. KEY MARKET DEVELOPMENTS
  • 1.5. INCIDENCE RATES INCLUDED
  • 1.6. PROCEDURE NUMBERS
  • 1.7. MARKETS INCLUDED
  • 1.8. KEY REPORT UPDATES
  • 1.9. VERSION HISTORY

RESEARCH METHODOLOGY

  • 2.1. RESEARCH SCOPE
  • 2.2. IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

CANCER INCIDENCE RATES

  • 3.1. INTRODUCTION
  • 3.2. CANCER BY TYPE
    • 3.2.1. Genital Cancer
    • 3.2.2. Digestive Cancer
    • 3.2.3. Respiratory Cancer
    • 3.2.4. Breast Cancer
    • 3.2.5. Urinary Cancer
    • 3.2.6. Skin Cancer
    • 3.2.7. Lymphoma
    • 3.2.8. Endocrine System Cancer
    • 3.2.9. Leukemia
    • 3.2.10. Oral Cavity/Larynx
    • 3.2.11. Myeloma
    • 3.2.12. Brain/Other Nervous System
    • 3.2.13. Soft Tissue (Non-Heart)
    • 3.2.14. Bones and Joints
    • 3.2.15. Eye and Orbit

TUMOR ABLATION DEVICE MARKET

  • 4.1. INTRODUCTION
    • 4.1.1. Modalities
      • 4.1.1.1. Cryoablation
      • 4.1.1.2. Radiofrequency Ablation
      • 4.1.1.3. Microwave Ablation Therapy
      • 4.1.1.4. Laser Ablation
      • 4.1.1.5. High Intensity Focused Ultrasound Ablation
      • 4.1.1.6. Irreversible Electroporation Ablation
  • 4.2. MARKET OVERVIEW
  • 4.3. MARKET ANALYSIS AND FORECAST
    • 4.3.1. Total Cryotherapy Ablation Market
      • 4.3.1.1. Cryotherapy Ablation Device Market
      • 4.3.1.2. Cryotherapy Ablation Device Rental Market
      • 4.3.1.3. Cryotherapy Ablation Probe Market
    • 4.3.2. Total Microwave Ablation Market
      • 4.3.2.1. Microwave Ablation Device Market
      • 4.3.2.2. Microwave Ablation Device Rental Market
      • 4.3.2.3. Microwave Ablation Probe Market
    • 4.3.3. Total RF Ablation Market
      • 4.3.3.1. RF Ablation Device Generator Market
      • 4.3.3.2. RF Ablation Device Disposables Market
  • 4.4. DRIVERS AND LIMITERS
    • 4.4.1. Market Drivers
    • 4.4.2. Market Limiters
  • 4.5. COMPETITIVE ANALYSIS

ABBREVIATIONS

LIST OF CHARTS

  • Chart 1-1: Interventional Oncology Device Market by Segment, U.S., 2012-2022 (US$M)
  • Chart 1-2: Interventional Oncology Device Market Overview, U.S., 2015 & 2022
  • Chart 3-1: Male Incidence, Genital Cancer, U.S., 2014
  • Chart 3-2: Male Deaths, Genital Cancer, U.S., 2014
  • Chart 3-3: Female Incidence, Genital Cancer, U.S., 2014
  • Chart 3-4: Female Deaths, Genital Cancer, U.S., 2014
  • Chart 3-5: Male Incidence, Digestive Cancer, U.S., 2014
  • Chart 3-6: Male Deaths, Digestive Cancer, U.S., 2014
  • Chart 3-7: Female Incidence, Digestive Cancer, U.S., 2014
  • Chart 3-8: Female Deaths, Digestive Cancer, U.S., 2014
  • Chart 3-9: Male Incidence, Respiratory Cancer, U.S., 2014
  • Chart 3-10: Male Deaths, Respiratory Cancer, U.S., 2014
  • Chart 3-11: Female Incidence, Respiratory Cancer, U.S., 2014
  • Chart 3-12: Female Deaths, Respiratory Cancer, U.S., 2014
  • Chart 3-13: Incidence by Gender, Breast Cancer, U.S., 2014
  • Chart 3-14: Deaths by Gender, Breast Cancer, U.S., 2014
  • Chart 3-15: Male Incidence, Urinary Cancer, U.S., 2014
  • Chart 3-16: Male Deaths, Urinary Cancer, U.S., 2014
  • Chart 3-17: Female Incidence, Urinary Cancer, U.S., 2014
  • Chart 3-18: Female Deaths, Urinary Cancer, U.S., 2014
  • Chart 3-19: Male Incidence, Skin Cancer, U.S., 2014
  • Chart 3-20: Male Deaths, Skin Cancer, U.S., 2014
  • Chart 3-21: Female Incidence, Skin Cancer, U.S., 2014
  • Chart 3-22: Female Deaths, Skin Cancer, U.S., 2014
  • Chart 3-23: Male Incidence, Lymphoma Cancer, U.S., 2014
  • Chart 3-24: Male Deaths, Lymphoma Cancer, U.S., 2014
  • Chart 3-25: Female Incidence, Lymphoma Cancer, U.S., 2014
  • Chart 3-26: Female Deaths, Lymphoma Cancer, U.S., 2014
  • Chart 3-27: Male Incidence, Endocrine Cancer, U.S., 2014
  • Chart 3-28: Male Deaths, Endocrine Cancer, U.S., 2014
  • Chart 3-29: Female Incidence, Endocrine Cancer, U.S., 2014
  • Chart 3-30: Female Deaths, Endocrine Cancer, U.S., 2014
  • Chart 3-31: Male Incidence, Leukemia Cancer, U.S., 2014
  • Chart 3-32: Male Deaths, Leukemia Cancer, U.S., 2014
  • Chart 3-33: Female Incidence, Leukemia Cancer, U.S., 2014
  • Chart 3-34: Female Deaths, Leukemia Cancer, U.S., 2014
  • Chart 3-35: Male Incidence, Oral Cavity/Larynx Cancer, U.S., 2014
  • Chart 3-36: Male Deaths, Oral Cavity/Larynx Cancer, U.S., 2014
  • Chart 3-37: Female Incidence, Oral Cavity/Larynx Cancer, U.S., 2014
  • Chart 3-38: Female Deaths, Oral Cavity/Larynx Cancer, U.S., 2014
  • Chart 3-39: Incidence by Gender, Myeloma Cancer, U.S., 2014
  • Chart 3-40: Deaths by Gender, Myeloma Cancer, U.S., 2014
  • Chart 3-41: Incidence by Gender, Brain/Other Nervous System Cancer, U.S., 2014
  • Chart 3-42: Deaths by Gender, Brain/Other Nervous System Cancer, U.S., 2014
  • Chart 3-43: Incidence by Gender, Soft Tissue Cancer, U.S., 2014
  • Chart 3-44: Deaths by Gender, Soft Tissue Cancer, U.S., 2014
  • Chart 3-45: Incidence by Gender, Bone and Joint Cancers, U.S., 2014
  • Chart 3-46: Deaths by Gender, Bone and Joint Cancers, U.S., 2014
  • Chart 3-47: Incidence by Gender, Eye and Orbit Cancers, U.S., 2014
  • Chart 3-48: Deaths by Gender, Eye and Orbit Cancers, U.S., 2014
  • Chart 4-1: Tumor Ablation Device Market by Segment, U.S., 2012-2022
  • Chart 4-2: Tumor Ablation Device Market Breakdown, U.S., 2015
  • Chart 4-3: Tumor Ablation Device Market Breakdown, U.S., 2022
  • Chart 4-4: Total Cryotherapy Ablation Market by Segment, U.S., 2012-2022
  • Chart 4-5: Cryotherapy Ablation Device Market, U.S., 2012-2022
  • Chart 4-6: Cryotherapy Ablation Device Rental Market, U.S., 2012-2022
  • Chart 4-7: Cryotherapy Ablation Probe Market, U.S., 2012-2022
  • Chart 4-8: Total Microwave Ablation Market by Segment, U.S., 2012-2022
  • Chart 4-9: Microwave Ablation Device Market, U.S., 2012-2022
  • Chart 4-10: Microwave Ablation Device Rental Market, U.S., 2012-2022
  • Chart 4-11: Microwave Ablation Probe Market, U.S., 2012-2022
  • Chart 4-12: Total RF Ablation Market by Segment, U.S., 2012-2022
  • Chart 4-13: RF Ablation Device Generator Market, U.S., 2012-2022
  • Chart 4-14: RF Ablation Device Disposables Market, U.S., 2012-2022
  • Chart 4-15: Leading Competitors, Ablation Device Market, 2015

LIST OF FIGURES

  • Figure 1-1: Interventional Oncology Device Market Share Ranking by Segment, U.S., 2015
  • Figure 1-2: Companies Research in this Report Suite, U.S., 2015
  • Figure 1-3: Factors Impacting the Interventional Oncology Device Market by Segment, U.S.
  • Figure 1-4: Recent Events in the Interventional Oncology Device Market, U.S., 2012-2015 (1 of 3)
  • Figure 1-5: Recent Events in the Interventional Oncology Device Market, U.S., 2012-2015 (2 of 3)
  • Figure 1-6: Recent Events in the Interventional Oncology Device Market, U.S., 2012-2015 (3 of 3)
  • Figure 1-7: Cancer Incidence Rates Covered, U.S., 2015 (1 of 2)
  • Figure 1-8: Cancer Incidence Rates Covered, U.S., 2015 (2 of 2)
  • Figure 1-9: Interventional Oncology Procedures Covered, U.S., 2015
  • Figure 1-10: Procedural Codes, U.S., 2015
  • Figure 1-11: Interventional Oncology Device Markets Covered, U.S., 2012-2022 (1 of 2)
  • Figure 1-12: Interventional Oncology Device Markets Covered, U.S., 2012-2022 (2 of 2)
  • Figure 1-13: Key Report Updates, U.S., 2016
  • Figure 1-14: Version History
  • Figure 3-1: Genital Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-2: Digestive Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-3: Respiratory Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-4: Breast Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-5: Urinary Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-6: Skin Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-7: Lymphoma Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-8: Endocrine Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-9: Leukemia Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-10: Oral Cavity/Larynx Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-11: Myeloma Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-12: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-13: Soft Tissue (Non-Heart) Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-14: Bone and Joint Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-15: Bone and Joint Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 4-1: Tumor Ablation Device Market by Segment, U.S., 2012-2022 (US$M)
  • Figure 4-2: Total Cryotherapy Ablation Market by Segment, U.S., 2012-2022 (US$M)
  • Figure 4-3: Cryotherapy Ablation Device Market, U.S., 2012-2022
  • Figure 4-4: Cryotherapy Ablation Device Rental Market, U.S., 2012-2022
  • Figure 4-5: Cryotherapy Ablation Probe Market, U.S., 2012-2022
  • Figure 4-6: Total Microwave Ablation Market by Segment, U.S., 2012-2022 (US$M)
  • Figure 4-7: Microwave Ablation Device Market, U.S., 2012-2022
  • Figure 4-8: Microwave Ablation Device Rental Market, U.S., 2012-2022
  • Figure 4-9: Microwave Ablation Probe Market, U.S., 2012-2022
  • Figure 4-10: Total RF Ablation Market by Segment, U.S., 2012-2022 (US$M)
  • Figure 4-11: RF Ablation Device Generator Market, U.S., 2012-2022
  • Figure 4-12: RF Ablation Device Disposables Market, U.S., 2012-2022
  • Figure 4-13: Drivers and Limiters, Ablation Device Market, U.S., 2015
  • Figure 4-14: Leading Competitors, Ablation Device Market, 2015
Back to Top